Description
Indication & Scope
KangShuTuo® Compound Ipratropium Bromide Solution for Inhalation treats reversible bronchospasm caused by obstructive airway diseases for patients requiring combined nebulized bronchodilator therapy.
- Mechanism: Ipratropium bromide blocks cholinergic receptors to reduce parasympathetic-mediated bronchoconstriction; salbutamol activates beta-2 adrenergic receptors to relax bronchial smooth muscle. The dual ingredients provide synergistic rapid and sustained bronchodilation.
- Drug class: Combination of anticholinergic bronchodilator and short-acting beta-2 agonist bronchodilator.
- Clinical use: Adjunct nebulization therapy for moderate to severe reversible airway obstruction in chronic obstructive pulmonary disease and asthma.
| Generic Name | Compound Ipratropium Bromide Solution for Inhalation |
| Brand Name | KangShuTuo |
| Ingredient | Ipratropium bromide, Salbutamol |
| Dosage Form | Inhalation |
| Package | 2ml: 0.25mg(calculated by C₂₀H₃₀BrNO₃)*8 ampoules/box;
2ml: 0.25mg(calculated by C₂₀H₃₀BrNO₃)*16 ampoules/box |
| Conditions Treated | Reversible bronchospasm secondary to obstructive airway diseases |
| Taboos | Hypersensitivity to ipratropium bromide, salbutamol, atropine derivatives or any excipients of the formulation |
| Place of origin | China |
| Prescription type | Prescription-only |
| Storage Conditions | Store at room temperature, keep sealed, protect from direct sunlight and freezing environment |
| Manufacturer | Jinyao Yongguang(Hebei) Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20234743 |
| Approval Date | Dec 29, 2023 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: One single dose vial for nebulization each time, maximum four times daily according to symptom severity.
Time: Administered on demand for acute bronchospasm or at regular intervals for persistent airway obstruction.
Instructions for use: Open the single-dose vial before use, pour all solution into nebulizer cup, complete nebulization inhalation continuously, discard residual liquid after use.
Interaction: Concomitant use with other anticholinergics or beta agonists increases adverse reaction risks; beta blockers may antagonize bronchodilator efficacy.
Side effects:
1. Common: dry mouth, mild tachycardia, hand tremor, throat irritation.
2. Rare: urinary retention, headache, palpitations.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What respiratory problem is suitable for Compound Ipratropium Bromide Solution for Inhalation?
It is applicable for reversible bronchospasm triggered by various obstructive airway diseases.
What is the advantage of Compound Ipratropium Bromide Solution for Inhalation the compound formula compared with single-ingredient bronchodilators?
The combination of anticholinergic and beta-2 agonist delivers synergistic and comprehensive airway dilation effects.
How to handle the residual liquid after opening the single-dose vial of Compound Ipratropium Bromide Solution for Inhalation?
Any residual solution must be discarded immediately without storage for repeated use.
What drug type will counteract the therapeutic effect of Compound Ipratropium Bromide Solution for Inhalation?
Beta blocker drugs can antagonize bronchodilation effects and should be avoided during medication.
KangShuTuo® | Compound Ipratropium Bromide Solution for Inhalation | Bronchospasm | DengYueRX
INN: Compound Ipratropium Bromide Solution for Inhalation
Indications: Bronchospasm
Dosage Form: Inhalation
Strength: 2ml: 0.25mg (calculated by C₂₀H₃₀BrNO₃) /ampoule
Original price was: $4.62.$3.93Current price is: $3.93.
Low MOQ
WHO-GMP
Worldwide Delivery
Compliance and Regulatory Documents
Related Products
